Juan Xu

2.8k citations
98 papers · 1.9k indexed · h-index 24
Topics
Cancer-related molecular mechanisms research (19 papers)RNA modifications and cancer (11 papers)Circular RNAs in diseases (9 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
ChinaUnited StatesFiji

In The Last Decade

Juan Xu

92 papers receiving 1.9k citations

Peers

Juan Xu
Comparison fields: 5 of 119
  • Molecular Biology 1.1k
  • Cancer Research 672
  • Oncology 382
  • Immunology 293
  • Surgery 172
Replace Yanhong Ni with:
Yanhong Ni China
Jinghuan Li China
Jean Lu Taiwan
Roopali Roy United States
Ting Hu China
Walburgis Brenner Germany
Chaoyang Sun China
Jingjing Qu China
Xianzhe Liu China
Juan Xu relative to Yanhong Ni China Yanhong Ni's profile →
Citations per field
00.5×1.5×
Yanhong Ni · 1×
Citations per year

Countries citing papers authored by Juan Xu

Since Specialization
Citations

This map shows the geographic impact of Juan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Xu more than expected).

Fields of papers citing papers by Juan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Xu. The network helps show where Juan Xu may publish in the future.

Co-authorship network of co-authors of Juan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Xu. A scholar is included among the top collaborators of Juan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Xu. Juan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 4
5 15
6 5
7 12
8 19
9
Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer Patients with a Survival Longer Than 5 Years
3
10 4
11 28
12 7
13 6
14 54
15 13
16 3
17 164
18 30
19 4
20 10

About Juan Xu

Juan Xu is a scholar working on Cancer Research, Reproductive Medicine and Oncology, having authored 98 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (11 papers) and Circular RNAs in diseases (9 papers). The work is most often cited by research in Cancer Research (672 citations), Molecular Biology (1.1k citations) and Reproductive Medicine (122 citations). Juan Xu has collaborated with scholars based in China, United States and Fiji. Frequent co-authors include Xuemei Jia, Pengfei Xu, Na Sheng, Ziyi Fu, Chencheng Dai, Teng Fang, Xingxu Huang, Yan Jiang, Fuzhou Ye and Chunmei Chen. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026